Free vitamin D and steroid metabolism in endocrine and kidney conditions
Official title: Free Fraction Vitamin D Measurements to Improve Understanding of Steroid Metabolism in Endocrine Disorders
Run by Universitaire Ziekenhuizen KU Leuven · NCT07268742 · Data updated 2026-11-12
This project will measure free (unbound) vitamin D and related steroid hormones in adults — including healthy people, pregnant women, and patients with endocrine or kidney disorders — to see how processing differs between groups.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 930 (estimated) |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven) |
| Status | Recruiting |
| Started | June 1, 2024 |
| Main results expected | October 2029 |
| Study ends | October 2029 |
| Registry record updated | December 8, 2025 |
| Trial ID | NCT07268742 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who can consent and fit one of the study cohorts — healthy controls, people with BMI ≥25 kg/m² (obesity cohort), chronic kidney disease stage ≥3a, women in first-trimester pregnancy, patients with primary hyperparathyroidism scheduled for parathyroidectomy, or those with complex calcium/phosphate disorders — are ideal candidates.
✕Probably not a fit
People under 18, those unable to give informed consent, or individuals whose clinical profile does not match any cohort (for example those taking excluded vitamin D or calcium supplementation when applicable) are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects blood samples from adults across several cohorts (healthy controls, people with obesity, chronic kidney disease stage ≥3a, first-trimester pregnancy, primary hyperparathyroidism scheduled for surgery, and complex calcium/phosphate disorders) to measure free and total vitamin D and related steroid markers. Laboratory assays will quantify free vitamin D, total vitamin D, vitamin D binding protein, and selected steroid metabolites to characterize binding and metabolic patterns. The study compares these measures between groups to determine whether total vitamin D testing reflects biologically available free vitamin D in different clinical contexts. Findings are intended to clarify how vitamin D results should be interpreted in pregnancy and in various endocrine and renal disorders.
Why it matters
Potential benefit: If successful, this could help doctors interpret vitamin D tests more accurately and lead to better diagnosis and treatment for people with pregnancy, endocrine, or kidney conditions.
How similar studies have gone: Previous research on the free vitamin D or 'free hormone' hypothesis has produced promising but mixed results, so the approach is emerging but not yet an established clinical standard.
Who can join: the full rules
Show full inclusion / exclusion criteria
1. General inclusion Criteria: \- 18 years or above 2. General exclusion Criteria: * Below 18 years of age * Individuals incapable of providing informed consent 3. Cohort inclusion criteria * Obesity: BMI ≥ 25 kg/m2 * Chronic Kidney Disease: ≥ CKD stage 3a (eGFR \< 60 mL/min/1.73m2) * Pregnancy: in trimester 1 of pregnancy * Primary hyperparathyroidism: diagnosis at UZ Leuven and scheduled for parathyroidectomy at UZ Leuven * Complex calcium and phosphate disorders: diagnosis at UZ Leuven 4. Cohort exclusion criteria * Healthy controls: BMI below 18 kg/m² or above 25 kg/m², pregnancy, chronic kidney disease (independent of staging), primary hyperparathyroidism and vitamin D and/or calcium supplementation * Obesity: chronic kidney disease (independent of staging), pregnancy, primary hyperparathyroidism * Chronic Kidney Disease: BMI below 18 kg/m² or above 30 kg/m², pregnancy, primary hyperparathyroidism * Pregnancy: BMI below 18 kg/m² or above 30 kg/m², chronic kidney disease (independent of staging), primary hyperparathyroidism * Primary hyperparathyroidism: BMI below 18 kg/m² or above 30 kg/m², pregnancy, chronic kidney disease (independent of staging), secondary hyperparathyroidism
Where it's running
-
University Hospitals Leuven
Leuven, Belgium Recruiting
Study contacts
- Principal investigator: Leen Antonio, MD, PhD — University Hospitals Leuven, Department of Endocrinology
- Study coordinator: Nick Narinx, MD
- Email: nick.narinx@uzleuven.be
- Phone: +3216348516
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High-intensity interval exercise to improve vitamin D levels in adults with overweight or obesity
This trial will try three hybrid high-intensity interval sessions per week for 12 weeks to see if exercise increases vitamin D (25(OH)D) in adults with overweight or obesity during winter.
-
Vitamin D to prevent recurrent pre-eclampsia in pregnant women
This study will test whether taking 4,000 IU of vitamin D during pregnancy lowers the chance of pre-eclampsia returning in women who had it in a prior pregnancy.
-
Sweet almonds to help heal femur and tibia shaft fractures
This test will see if eating sweet almonds helps adults aged 18–55 with trauma-related femur or tibia shaft fractures heal their bones faster and safely.
-
Vitamin D supplementation for obese children
This study is testing whether different doses of vitamin D can help obese kids and teens improve their insulin levels and body fat over six months.
-
Combination of natural supplements for treating uterine fibroids
This study is testing a mix of natural supplements to see if they can reduce the size of larger uterine fibroids in women who have them.
-
Vitamin D Supplementation in Children with Irritable Bowel Syndrome
This study tests whether giving vitamin D to children with IBS and low vitamin D levels can improve their IBS symptoms compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.